Israel - English - Ministry of Health

astrazeneca (israel) ltd - saxagliptin as hydrochloride - film coated tablets - saxagliptin as hydrochloride 5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Israel - English - Ministry of Health

astrazeneca (israel) ltd - saxagliptin as hydrochloride - film coated tablets - saxagliptin as hydrochloride 2.5 mg - saxagliptin - saxagliptin - monotherapy: onglyza is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.onglyza should not be used in patients with esrdcombination therapy: add-on combination: onglyza is indicated in patients with type 2 diabetes mellitus to improve glycemic control in combination with metformin, a thiazolidinedione (tzd), or a sulfonylurea (su), when the single agent alone, with diet and exercise, does not provide adequate glycemic control.initial combination: onglyza is indicated for use as initial combination therapy with metformin, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes mellitus when dual saxagliptin and metformin therapy is appropriate.onglyza should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. in combination with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.

Israel - English - Ministry of Health

lundbeck israel ltd. - zuclopenthixol decanoate - oily solution for injection - zuclopenthixol decanoate 500 mg/ml - zuclopenthixol - zuclopenthixol - acute schizophrenia, other acute psychoses.

Israel - English - Ministry of Health

lundbeck israel ltd. - zuclopenthixol decanoate - oily solution for injection - zuclopenthixol decanoate 200 mg/ml - zuclopenthixol - zuclopenthixol - clopixol depot injection is a depot neuroleptic preparation designed for the maintenance treatment of acute and chronic schizophrenia and other paranoid psychoses, especially where compliance with oral medication is a problem.

Israel - English - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride - tablets sublingual - buprenorphine as hydrochloride 8 mg - buprenorphine - buprenorphine - substitution treatment for opioid dependence within a framework of medical, social and psychological treatment.

Israel - English - Ministry of Health

naomi shaco-ezra ltd - buprenorphine as hydrochloride - tablets sublingual - buprenorphine as hydrochloride 2 mg - buprenorphine - buprenorphine - substitution treatment for opioid dependence within a framework of medical, social and psychological treatment.

Israel - English - Ministry of Health

abbott medical laboratories ltd, israel - omega-3 acid ethyl esters - capsules - omega-3 acid ethyl esters 1000 mg - omega-3-triglycerides - omega-3-triglycerides - post myocardial infarction: adjuvant treatment in secondary prevention after myocardial infarction, in addition to other standard therapy (e.g. statins, antiplatelet drugs, betablockers, ace inhibitors). hypertriglyceridaemia: endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response: - type iv hypertriglyceridaemia. - type iib/iii hypertriglyceridaemia in combination with statin, when control of triglycerides by statins is insufficient.

Israel - English - Ministry of Health

unipharm ltd, israel - fluoxetine as hydrochloride - coated tablets - fluoxetine as hydrochloride 20 mg - fluoxetine - fluoxetine - prizma is indicated for the treatment of depression and obsessive-compulsive disorders (ocd). for the treatment of binge-eating and vomiting behaviors in bulimia nervosa.

Israel - English - Ministry of Health

unipharm ltd, israel - fluoxetine as hydrochloride - tablets - fluoxetine as hydrochloride 60 mg - fluoxetine - fluoxetine - prizma is indicated for the treatment of depression and obsessive-compulsive disorders (ocd). for the treatment of binge-eating and vomiting behaviors in bulimia nervosa.

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - pegvisomant - powder and solvent for solution for injection - pegvisomant 25 mg/vial - pegvisomant - treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy, and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf-i concentrations or was not tolerated.